losartan has been researched along with iofetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashida, K; Miyashita, K; Moriwaki, H; Nagakane, Y; Naritomi, H; Uno, H | 1 |
Kobayashi, M; Kuroda, H; Ogasawara, K; Ogawa, A; Saura, H; Suzuki, T; Terasaki, K; Yamashita, T | 1 |
2 other study(ies) available for losartan and iofetamine
Article | Year |
---|---|
Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain; Cerebrovascular Circulation; Female; Humans; Hypertension; Iofetamine; Losartan; Male; Middle Aged; Radiopharmaceuticals; Stroke; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusiv
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Occlusive Diseases; Carotid Stenosis; Cerebral Arterial Diseases; Cerebrovascular Circulation; Cerebrovascular Disorders; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Iofetamine; Losartan; Male; Middle Aged; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2012 |